Parallel imports can be repackaged

摘要

Parallel importers can repackage branded medicines if they need to do so to gain market acceptability for these products.After putting questions to the European Court,the Court of Appeal upheld an earlier High Court judgment against Boehringer Ingelheim,Glaxo Group,SmithKline Beecham and Eli Lilly.